A carregar...
Valproate inhibits glucose-stimulated insulin secretion in beta cells
Valproate (VPA), an FDA approved anti-epileptic drug with a half-life of 12–18h in humans, has been shown to perturb the vacuolar proton pump (vH(+)-ATPase) function in yeasts by inhibiting myo-inositol phosphate synthase, the first and rate-limiting enzyme in inositol biosynthesis, thereby resultin...
Na minha lista:
| Publicado no: | Histochem Cell Biol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6719693/ https://ncbi.nlm.nih.gov/pubmed/30145684 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00418-018-1713-6 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|